Eosera Inc.
FDA inspection history in Fort Worth, Texas, 2020 to 2026
- 2
- Form 483s
- 1
- Close-out
Every document, by year
- Form 483
- Close-out
2020: one close-out letter and one Form 483; 2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2020One close-out letter and one Form 483, at Fort Worth, Texas.
- 2026One Form 483, at Fort Worth, Texas.
- 2026The longest 483 on file: 10 observations over 11 pages at Fort Worth, Texas.
Cited most
Across all Eosera observations on file
- 21 CFR 211.84(d)(2)Testing and approval or rejection of components, drug product containers, and closures4
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.165(f)Testing and release for distribution1
The complete Eosera file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Fort Worth, Texas
Two Form 483s and one close-out letter · 2020 to 2026 · 15 observations
Latest: Form 483, Mar 20, 2026 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-03-20 | 483 Form 483 | Fort Worth, Texas | 10 | $99 |
| 2020-07-13 | Close-out Close-out letter | Fort Worth, Texas | — | $99 |
| 2020-01-17 | 483 Form 483 | Fort Worth, Texas | 5 | $99 |
Investigators on these documents
Margaret M. Annes (1)Oluwasefunmi Agbanigo (1)Patty P. Kaewussdangkul (1)Shanna N. Purdy (1)
FEI number 3013559620 · most recent document Mar 20, 2026
About Eosera Inc.
How many FDA Form 483s has Eosera Inc. received?
FDA Intel has 2 Form 483s on file for Eosera Inc.; the most recent is dated Mar 20, 2026.
When was Eosera Inc. last inspected by FDA?
The most recent FDA inspection document on file for Eosera Inc. is a Form 483 dated Mar 20, 2026, for the site in Fort Worth, Texas.
What did FDA cite at Eosera Inc.?
The regulations cited most in the observations on file for Eosera Inc. are 21 CFR 211.84(d)(2) (Testing and approval or rejection of components, drug product containers, and closures), 4 times; 21 CFR 211.100(a) (Written procedures; deviations), 1 time; 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time.